130 related articles for article (PubMed ID: 12630288)
21. Comparative genomic hybridisation arrays: high-throughput tools to determine targeted therapy in breast cancer.
Tan DS; Reis-Filho JS
Pathobiology; 2008; 75(2):63-74. PubMed ID: 18544961
[TBL] [Abstract][Full Text] [Related]
22. The role of genomics and proteomics: technologies in studying non-alcoholic fatty liver disease.
Baranova A; Liotta L; Petricoin E; Younossi ZM
Clin Liver Dis; 2007 Feb; 11(1):209-20, xi. PubMed ID: 17544980
[TBL] [Abstract][Full Text] [Related]
23. Proteomic methods for drug target discovery.
Sleno L; Emili A
Curr Opin Chem Biol; 2008 Feb; 12(1):46-54. PubMed ID: 18282485
[TBL] [Abstract][Full Text] [Related]
24. Tools for target identification and validation.
Wang S; Sim TB; Kim YS; Chang YT
Curr Opin Chem Biol; 2004 Aug; 8(4):371-7. PubMed ID: 15288246
[TBL] [Abstract][Full Text] [Related]
25. Herbogenomics: from traditional Chinese medicine to novel therapeutics.
Kang YJ
Exp Biol Med (Maywood); 2008 Sep; 233(9):1059-65. PubMed ID: 18535158
[TBL] [Abstract][Full Text] [Related]
26. The application of genomic and proteomic technologies in predictive, preventive and personalized medicine.
Collins CD; Purohit S; Podolsky RH; Zhao HS; Schatz D; Eckenrode SE; Yang P; Hopkins D; Muir A; Hoffman M; McIndoe RA; Rewers M; She JX
Vascul Pharmacol; 2006 Nov; 45(5):258-67. PubMed ID: 17030152
[TBL] [Abstract][Full Text] [Related]
27. Role of Toll-like receptors in antisense and siRNA [corrected].
Agrawal S; Kandimalla ER
Nat Biotechnol; 2004 Dec; 22(12):1533-7. PubMed ID: 15583662
[TBL] [Abstract][Full Text] [Related]
28. Microarrays to identify new therapeutic strategies for cancer.
Sears C; Armstrong SA
Adv Cancer Res; 2007; 96():51-74. PubMed ID: 17161676
[TBL] [Abstract][Full Text] [Related]
29. Post-genomic vaccine development.
Serruto D; Rappuoli R
FEBS Lett; 2006 May; 580(12):2985-92. PubMed ID: 16716781
[TBL] [Abstract][Full Text] [Related]
30. From proteins to proteomics.
Bradshaw RA; Burlingame AL
IUBMB Life; 2005; 57(4-5):267-72. PubMed ID: 16036609
[TBL] [Abstract][Full Text] [Related]
31. A computational approach for ordering signal transduction pathway components from genomics and proteomics Data.
Liu Y; Zhao H
BMC Bioinformatics; 2004 Oct; 5():158. PubMed ID: 15504238
[TBL] [Abstract][Full Text] [Related]
32. Array-based proteomics: high-throughput expression and purification of IMAGE consortium cDNA clones.
Albala JS; Humphery-Smith I
Curr Opin Mol Ther; 1999 Dec; 1(6):680-4. PubMed ID: 19629864
[TBL] [Abstract][Full Text] [Related]
33. Integrative genomics based identification of potential human hepatocarcinogenesis-associated cell cycle regulators: RHAMM as an example.
Yang CW; Su JY; Tsou AP; Chau GY; Liu HL; Chen CH; Chien CY; Chou CK
Biochem Biophys Res Commun; 2005 May; 330(2):489-97. PubMed ID: 15796909
[TBL] [Abstract][Full Text] [Related]
34. Genetics, genomics and proteomics in atherosclerosis research.
Tuomisto TT; Binder BR; Ylä-Herttuala S
Ann Med; 2005; 37(5):323-32. PubMed ID: 16179268
[TBL] [Abstract][Full Text] [Related]
35. RNA interference: a novel and physiologic mechanism of gene silencing with great therapeutic potential.
Calderón AJ; Lavergne JA
P R Health Sci J; 2005 Mar; 24(1):27-33. PubMed ID: 15895874
[TBL] [Abstract][Full Text] [Related]
36. Ribonucleic acid interference for neurological disorders: candidate diseases, potential targets, and current approaches.
Federici T; Boulis NM
Neurosurgery; 2007 Jan; 60(1):3-15; discussion 15-6. PubMed ID: 17228249
[TBL] [Abstract][Full Text] [Related]
37. Array of informatics: Applications in modern research.
Kozarova A; Petrinac S; Ali A; Hudson JW
J Proteome Res; 2006 May; 5(5):1051-9. PubMed ID: 16674093
[TBL] [Abstract][Full Text] [Related]
38. Prostate cancer and the genomic revolution: Advances using microarray analyses.
Calvo A; Gonzalez-Moreno O; Yoon CY; Huh JI; Desai K; Nguyen QT; Green JE
Mutat Res; 2005 Aug; 576(1-2):66-79. PubMed ID: 15950992
[TBL] [Abstract][Full Text] [Related]
39. Can medical genetics and evolutionary biology inspire drug target identification?
Wang ZY; Fu LY; Zhang HY
Trends Mol Med; 2012 Feb; 18(2):69-71. PubMed ID: 22172275
[TBL] [Abstract][Full Text] [Related]
40. Main approaches to target discovery and validation.
Sioud M
Methods Mol Biol; 2007; 360():1-12. PubMed ID: 17172722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
